The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy
Go back to The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 9.06 -0.36 (3.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.42 | 52 Week High | $5.40 | |||
| Open | $9.30 | 52 Week Low | $1.88 | |||
| Day High | $9.36 | P/E | N/A | |||
| Day Low | $8.96 | EPS | $0.00 | |||
| Volume | 3,253,084 | |||||
